Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 1
1980 4
1981 3
1982 5
1983 6
1984 4
1985 3
1986 9
1987 5
1988 3
1989 4
1990 7
1991 7
1992 10
1993 8
1994 12
1995 19
1996 12
1997 24
1998 36
1999 46
2000 42
2001 51
2002 37
2003 52
2004 70
2005 85
2006 116
2007 116
2008 131
2009 191
2010 210
2011 230
2012 278
2013 314
2014 342
2015 382
2016 385
2017 442
2018 452
2019 587
2020 750
2021 814
2022 1060
2023 1002
2024 1030
2025 1174
2026 580

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10,004 results

Results by year

Filters applied: . Clear all
Page 1
EcDNA-borne structural variants drive oncogenic fusion transcript amplification.
Yi H, Zhang S, Swinderman J, Wang Y, Kanakaveti V, Hung KL, Tsz-Lo Wong I, Srinivasan S, Curtis EJ, Bhargava-Shah A, Li R, Jones MG, Luebeck J, Bailey C, Zhao Y, Belk JA, Kraft K, Shi Q, Yan X, Pritchard SK, Mahajan KS, Liang F, Jamal-Hanjani M, Felsher DW, Gilbert LA, Bafna V, Mischel PS, Chang HY. Yi H, et al. Among authors: shi q. Cell. 2026 Feb 5;189(3):906-921.e20. doi: 10.1016/j.cell.2025.12.009. Epub 2026 Jan 7. Cell. 2026. PMID: 41506267 Free article.
Ivonescimab plus chemotherapy versus tislelizumab plus chemotherapy in advanced squamous non-small-cell lung cancer (HARMONi-6): interim overall survival analysis of a randomised, double-blind, phase 3 trial in China.
Lu S, Liu B, Luo Y, Sun L, Wu L, Han Z, Fan Y, Zhao Y, Li X, Xu H, Meng X, Liu Y, Zhang Z, Luo H, Ma X, Ma X, Shi Q, Zhang Z, Yang R, Wang P, Pan P, Ai X, Li J, Pu X, Wang Z, Fang J, He M, He Y, Guo S, Li J, Wang H, Zhang J, Chu Q, Liu X, Ying S, Wu H, Sun H, Ji Y, Zhou M, Cao C, Tang K, Li Z, Li D, Zhang Z, Li J, Zhou J, Yang H, Du Y, Yang H, Shi J, Chen H, Chen Z, Li W, Lu D, Hu M, Wang ZM, Li B, Xia MY. Lu S, et al. Among authors: shi q. Lancet. 2026 May 31:S0140-6736(26)00966-9. doi: 10.1016/S0140-6736(26)00966-9. Online ahead of print. Lancet. 2026. PMID: 42218899
Natural ovulation versus programmed regimens before frozen embryo transfer in ovulatory women: multicentre, randomised clinical trial.
Wei D, Qin Y, Sun Y, Yan J, Zhao H, Guan Y, Tan J, Guo T, Wang Z, Gong F, Hao C, Ma X, Zhang C, Zhang A, Geng L, Sun M, Li X, Ling X, Lu Q, Bao H, Chao L, Huang W, Shi Q, Zhao J, Lu Y, Wu S, Zhang S, Wang J, Guo M, Sun X, Ma Y, Wu Q, Li Y, Ou X, Fang Z, Chen J, Hao G, Zhang H, Legro RS, Chen ZJ; PnROVE Study Group. Wei D, et al. Among authors: shi q. BMJ. 2026 Jan 21;392:e087045. doi: 10.1136/bmj-2025-087045. BMJ. 2026. PMID: 41565309 Free PMC article. Clinical Trial.
Oxygen Therapy for Intracranial Hemorrhage.
Shi Q, Han S, Li X, Guan J, Duan Y, Liao Z, Chen Z, Li W, Meng R, Zou M, Ding J. Shi Q, et al. CNS Neurosci Ther. 2026 Feb;32(2):e70806. doi: 10.1002/cns.70806. CNS Neurosci Ther. 2026. PMID: 41735793 Free PMC article. Review.
Socioeconomic inequalities in cancer survival and access to health care among children and adolescents in China, 2018-24: a prospective nationwide cohort study.
Ni X, Li Z, Liu Y, Li X, Bai G, Lu M, Yang Z, Xu X, Zhao W, Cheng KK, Zhang Y, Zheng R, Liu Y, Jia C, Wang X, Wang Y, Shi Q, Yao X, Zhang Y, Su Y, Wang S, Deng Z, Yang W, Duan Y, Zhang R, Wang X, Mao H, Liu S, Li J, Zhang T. Ni X, et al. Among authors: shi q. Lancet. 2026 Jan 17;407(10525):237-255. doi: 10.1016/S0140-6736(25)01911-7. Epub 2025 Dec 23. Lancet. 2026. PMID: 41453383
Lipid nanoparticles for cell and gene therapy.
Han X, Shi Q, Mitchell MJ. Han X, et al. Among authors: shi q. Mol Ther Adv. 2026 Jan 20;34(1):201671. doi: 10.1016/j.omta.2026.201671. eCollection 2026 Mar 12. Mol Ther Adv. 2026. PMID: 42137275 Free PMC article. No abstract available.
Clinical practice guideline for long COVID prevention and treatment.
Cao B, Soriano JB, Wang Q, Al-Aly Z, Gu X, Wang G, Leo YS, Jin Y, Shi Q, Ohmagari N, Liu E, Paredes R, Lu H, Kim ES, Zhang D, Estill J, Li L, Spruyt K, Yang W, Wang Y, Ran M, Luo X, Zhang H, Xu J, Zhang R, Zhao J, Zhao J, Evans RA, Jeon J, Peluso MJ, Errett LE, Zhang W, Chalmers JD, Chen Y; Multidisciplinary Working Group on Long COVID Practice Guidelines (MWG-LCPG). Cao B, et al. Among authors: shi q. Eur Respir J. 2026 Mar 19:2502611. doi: 10.1183/13993003.02611-2025. Online ahead of print. Eur Respir J. 2026. PMID: 41856572 Free article.
10,004 results
You have reached the last available page of results. Please see the User Guide for more information.